A Multicenter Feasibility Study with S-1, Oxaliplatin and Oral Leucovorin (SOL) for the Patients with Untreated Metastatic Colorectal Cancer: The Result of Final Analysis.

CONCLUSIONS: This result indicates that the SOL regimen is well tolerated and effective in Chinese patients with metastatic colorectal cancer. PMID: 26158159 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26158159?dopt=Abstract

Source: Hepato-Gastroenterology - July 12, 2015 Category: Gastroenterology Tags: Hepatogastroenterology Source Type: research